How has been the historical performance of Nureca?
Nureca's historical performance has shown significant fluctuations, with net sales peaking at 255.55 Cr in Mar'22 and declining to 109.66 Cr by Mar'25. Despite challenges, the company reported a net profit of 0.85 Cr in Mar'25, marking a recovery from previous losses.
Answer:The historical performance of Nureca shows significant fluctuations in its financial metrics over the years.Breakdown:
Nureca's net sales have varied considerably, peaking at 255.55 Cr in Mar'22, before declining to 109.66 Cr in Mar'25. The total operating income followed a similar trend, reaching a high of 255.55 Cr in Mar'22 and dropping to 109.66 Cr by Mar'25. The company's total expenditure, excluding depreciation, also saw a decline from 200.04 Cr in Mar'22 to 117.20 Cr in Mar'25. Operating profit (PBDIT) was positive at 63.21 Cr in Mar'22 but turned negative in subsequent years, culminating in a loss of 7.54 Cr in Mar'25. Despite these challenges, Nureca reported a profit before tax of 1.34 Cr in Mar'25, a recovery from the losses of previous years. The net profit also improved to 0.85 Cr in Mar'25, compared to losses in the two preceding years. The earnings per share (EPS) reflected this trend, moving from a high of 46.37 in Mar'21 to 0.85 in Mar'25. Cash flow from operating activities has been negative in recent years, with a cash outflow of 19.00 Cr in Mar'25, while cash flow from investing activities showed a positive inflow of 8.00 Cr in the same period. Overall, Nureca's financial performance has experienced significant ups and downs, with a notable recovery in net profit in the latest fiscal year.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
